Francesca Palandri: Highlighting Innovation in Rare Disease Care at EHA 2026
Francesca Palandri, Hematologist at Sant’Orsola-Malpighi Polyclinic – Bologna University Hospital, shared a post on LinkedIn:
“EHA 2026 – Stockholm | Myeloproliferative neoplasms
I am grateful to La Piazza Avvenimenti for the attention with which he told about my participation in the educational session ‘Modern approaches to ET and PV’, in which I talked about:
- Risk stratification
- Innovative therapies
- Multidisciplinary and patient-centered approach
That a newspaper born from the world of commerce and business dedicates space to the themes of health and innovation in rare diseases says a lot: it means recognizing that 360-degree personal care is not just about medicine, but is a value that crosses society, work, and the community.
It is a look at progress and passion, capable of holding together the interest of the community and attention to the individual: the same logic that guides good medicine.
Thanks to La Piazza Avvenimenti for this sensitivity, and thanks always to IRCCS Policlinico di Sant’Orsola – Azienda Ospedaliero Universitaria di Bologna and Alma Mater Studiorum – Università di Bologna.”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering